Search research articles
Contact Us
Filters
Showing results (121-130 of 181) with videos related to
Page
of 19
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
October 9, 2025
SNMMI/EANM/ACNM Procedure Standard/Procedure Guideline on the Use of Molecular Imaging for Renal Mass Characterization
Steven P Rowe, Brian M Shuch, Mark W Ball, et al.
Investigational New Drugs
|
August 7, 2012
Phase I/II study of pegylated arginine deiminase (ADI-PEG 20) in patients with advanced melanoma
Patrick A Ott, Richard D Carvajal, Neeta Pandit-Taskar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 30, 2013
Phase II study of Lutetium-177-labeled anti-prostate-specific membrane antigen monoclonal antibody J591 for metastatic castration-resistant prostate cancer
Scott T Tagawa, Matthew I Milowsky, Michael Morris, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 5, 2022
Treatment of Patients with Acute Myeloid Leukemia with the Targeted Alpha-Particle Nanogenerator Actinium-225-Lintuzumab
Todd L Rosenblat, Michael R McDevitt, Jorge A Carrasquillo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 22, 2010
Farletuzumab, a humanized monoclonal antibody against folate receptor alpha, in epithelial ovarian cancer: a phase I study
Jason A Konner, Katherine M Bell-McGuinn, Paul Sabbatini, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
May 9, 2013
Phase I pharmacokinetic and biodistribution study with escalating doses of ²²³Ra-dichloride in men with castration-resistant metastatic prostate cancer
Jorge A Carrasquillo, Joseph A O'Donoghue, Neeta Pandit-Taskar, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
February 13, 2025
Computational Nuclear Oncology Toward Precision Radiopharmaceutical Therapies: Current Tools, Techniques, and Uncharted Territories
Tahir Yusufaly, Emilie Roncali, Julia Brosch-Lenz, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
August 7, 2025
Lesion Absorbed Dose-Response Relationship in Patients with Metastatic Castration-Resistant Prostate Cancer Undergoing [<sup>177</sup>Lu]Lu-PSMA-617 Radiopharmaceutical Therapy
Milan Grkovski, Simone S Krebs, Joseph A O'Donoghue, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
June 30, 2019
European Association of Nuclear Medicine Practice Guideline/Society of Nuclear Medicine and Molecular Imaging Procedure Standard 2019 for radionuclide imaging of phaeochromocytoma and paraganglioma
David Taïeb, Rodney J Hicks, Elif Hindié, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
October 3, 2007
Targeting Lewis Y (Le(y)) in small cell lung cancer with a humanized monoclonal antibody, hu3S193: a pilot trial testing two dose levels
Lee M Krug, Daniel T Milton, Achim A Jungbluth, et al.
Page
of 19
Search research articles
Search
Showing results (121-130 of 181) with videos related to
Sort By:
Page
of 19
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
October 9, 2025
SNMMI/EANM/ACNM Procedure Standard/Procedure Guideline on the Use of Molecular Imaging for Renal Mass Characterization
Steven P Rowe, Brian M Shuch, Mark W Ball, et al.
Investigational New Drugs
|
August 7, 2012
Phase I/II study of pegylated arginine deiminase (ADI-PEG 20) in patients with advanced melanoma
Patrick A Ott, Richard D Carvajal, Neeta Pandit-Taskar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 30, 2013
Phase II study of Lutetium-177-labeled anti-prostate-specific membrane antigen monoclonal antibody J591 for metastatic castration-resistant prostate cancer
Scott T Tagawa, Matthew I Milowsky, Michael Morris, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 5, 2022
Treatment of Patients with Acute Myeloid Leukemia with the Targeted Alpha-Particle Nanogenerator Actinium-225-Lintuzumab
Todd L Rosenblat, Michael R McDevitt, Jorge A Carrasquillo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 22, 2010
Farletuzumab, a humanized monoclonal antibody against folate receptor alpha, in epithelial ovarian cancer: a phase I study
Jason A Konner, Katherine M Bell-McGuinn, Paul Sabbatini, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
May 9, 2013
Phase I pharmacokinetic and biodistribution study with escalating doses of ²²³Ra-dichloride in men with castration-resistant metastatic prostate cancer
Jorge A Carrasquillo, Joseph A O'Donoghue, Neeta Pandit-Taskar, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
February 13, 2025
Computational Nuclear Oncology Toward Precision Radiopharmaceutical Therapies: Current Tools, Techniques, and Uncharted Territories
Tahir Yusufaly, Emilie Roncali, Julia Brosch-Lenz, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
August 7, 2025
Lesion Absorbed Dose-Response Relationship in Patients with Metastatic Castration-Resistant Prostate Cancer Undergoing [<sup>177</sup>Lu]Lu-PSMA-617 Radiopharmaceutical Therapy
Milan Grkovski, Simone S Krebs, Joseph A O'Donoghue, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
June 30, 2019
European Association of Nuclear Medicine Practice Guideline/Society of Nuclear Medicine and Molecular Imaging Procedure Standard 2019 for radionuclide imaging of phaeochromocytoma and paraganglioma
David Taïeb, Rodney J Hicks, Elif Hindié, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
October 3, 2007
Targeting Lewis Y (Le(y)) in small cell lung cancer with a humanized monoclonal antibody, hu3S193: a pilot trial testing two dose levels
Lee M Krug, Daniel T Milton, Achim A Jungbluth, et al.
Page
of 19